Search Results for " Cobimetinib "
Cobimetinib Related Products
Cobimetinib is an antineoplastic agent and selective inhibitor of the mitogen-activated extracellular kinase (MEK) pathway used to treat unresectable or metastatic melanoma.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Cobimetinib, pharmacopeial and non-pharmacopeial Cobimetinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Cobimetinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Cobimetinib-related products are thoroughly characterized. Cobimetinib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.